Challenges in managing HIV in people who use drugs

Current Opinion in Infectious Diseases - Tập 28 Số 1 - Trang 10-16 - 2015
Adeeba Kamarulzaman1, Frederick L. Altice
1aCentre of Excellence for Research in AIDS (CERiA), University of Malaya, Faculty of Medicine, Kuala Lumpur, Malaysia bYale University, School of Medicine, Section of Infectious Diseases cYale University, School of Public Health, Section of Epidemiology of Microbial Diseases, New Haven, Connecticut, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Vermund, 2014, Global HIV epidemiology: a guide for strategies in prevention and care., Curr HIVAIDS Rep, 11, 93, 10.1007/s11904-014-0208-x

Baum, 2009, Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users., J Acquir Immune Defic Syndr, 50, 93, 10.1097/QAI.0b013e3181900129

Altice, 2010, Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs., Lancet, 376, 59, 10.1016/S0140-6736(10)60829-X

Meyer, 2013, Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities., Clin Infect Dis, 57, 1309, 10.1093/cid/cit427

Wolfe, 2007, Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union., Int J Drug Policy, 18, 246, 10.1016/j.drugpo.2007.01.012

Milloy, 2011, Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users., J Infect Dis, 203, 1215, 10.1093/infdis/jir032

Milloy, 2012, Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review., AIDS, 26, 1049, 10.1097/QAD.0b013e32835221cc

Donoghoe, 2007, Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004., Int J Drug Policy, 18, 271, 10.1016/j.drugpo.2007.02.010

Hakansson, 2013, All-cause mortality in criminal justice clients with substance use problems - a prospective follow-up study., Drug Alcohol Depend, 132, 499, 10.1016/j.drugalcdep.2013.03.014

Moore, 2013, Nonfatal overdose among adult prisoners with a history of injecting drug use in two Australian states., Drug Alcohol Depend, 133, 45, 10.1016/j.drugalcdep.2013.06.001

Pabayo, 2013, The role of depression and social support in nonfatal drug overdose among a cohort of injection drug users in a Canadian setting., Drug Alcohol Depend, 132, 603, 10.1016/j.drugalcdep.2013.04.007

Bartoli, 2014, Association between depression and nonfatal overdoses among drug users: a systematic review and meta-analysis., Drug Alcohol Depend, 134, 12, 10.1016/j.drugalcdep.2013.10.007

Aceijas, 2006, Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the Treating 3 million by 2005. Making it happen. The WHO strategy (3 by 5)., Addiction, 101, 1246, 10.1111/j.1360-0443.2006.01509.x

Wolfe, 2010, Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward., Lancet, 376, 355, 10.1016/S0140-6736(10)60832-X

Gardner, 2011, The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection., Clin Infect Dis, 52, 793, 10.1093/cid/ciq243

Chakrapani, 2014, Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India., AIDS Care, 26, 835, 10.1080/09540121.2013.861573

Terlikbayeva, 2013, Access to HIV counseling and testing among people who inject drugs in Central Asia: strategies for improving access and linkages to treatment and care., Drug Alcohol Depend, 132, S61, 10.1016/j.drugalcdep.2013.07.007

Bojko, 2013, At the crossroads: HIV prevention and treatment for people who inject drugs in Ukraine., Addiction, 108, 1697, 10.1111/add.12243

Izenberg, 2010, Next steps for Ukraine - abolition of HIV registries, implementation of routine HIV testing and expansion of services., Addiction, 105, 569, 10.1111/j.1360-0443.2009.02881.x

Samet, 1998, Trillion virion delay: time from testing positive for HIV to presentation for primary care., Arch Intern Med, 158, 734, 10.1001/archinte.158.7.734

Metsch, 2012, Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial., Am J Public Health, 102, 1160, 10.2105/AJPH.2011.300460

Chadwick, 2014, Correlates of having never been HIV tested among entrants to substance abuse treatment clinics: empiric findings from real-world New England settings., J Psychoactive Drugs, 46, 208, 10.1080/02791072.2014.915363

Liebman, 2002, Effectiveness of a mobile medical van in providing screening services for STDs and HIV., Public Health Nurs, 19, 345, 10.1046/j.1525-1446.2002.19504.x

Lipsitz, 2014, Bringing testing to the people: benefits of mobile unit HIVsyphilis testing in Lima, Peru, 2007-2009., Int J STD AIDS, 25, 325, 10.1177/0956462413507443

Markwick, 2014, Willingness to engage in peer-delivered HIV voluntary counselling and testing among people who inject drugs in a Canadian setting., J Epidemiol Community Health, 68, 675, 10.1136/jech-2013-203707

Bruce, 2007, Clinical care of the HIV-infected drug user., Infect Dis Clin North Am, 21, 149, 10.1016/j.idc.2007.03.009

Mehta, 2010, Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland., Clin Infect Dis, 50, 1664, 10.1086/652867

Rodriguez-Arenas, 2006, Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain., AIDS Res Hum Retroviruses, 22, 715, 10.1089/aid.2006.22.715

Malta, 2010, Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis., AIDS Behav, 14, 731, 10.1007/s10461-008-9489-7

Westergaard, 2012, Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers., J Int AIDS Soc, 15, 10, 10.1186/1758-2652-15-10

Wood, 2008, A review of barriers and facilitators of HIV treatment among injection drug users., AIDS, 22, 1247, 10.1097/QAD.0b013e3282fbd1ed

Ding, 2005, Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users., Arch Intern Med, 165, 618, 10.1001/archinte.165.6.618

Werb, 2010, Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis., Lancet Infect Dis, 10, 464, 10.1016/S1473-3099(10)70097-9

Ostertag, 2006, Trust and other characteristics associated with healthcare utilization by injection drug users., J Drug Issues, 36, 953, 10.1177/002204260603600409

Merrill, 2002, Mutual mistrust in the medical care of drug users: the keys to the narc cabinet., J Gen Intern Med, 17, 327

Altice, 2001, Trust and the acceptance of and adherence to antiretroviral therapy., J Acquir Immune Defic Syndr, 28, 47, 10.1097/00042560-200109010-00008

Fu, 2012, Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers., PLoS One, 7, e44249, 10.1371/journal.pone.0044249

Kerr, 2014, The impact of compulsory drug detention exposure on the avoidance of healthcare among injection drug users in Thailand., Int J Drug Policy, 25, 171, 10.1016/j.drugpo.2013.05.017

Beyrer, 2011, Expanding the space: inclusion of most-at-risk populations in HIV prevention, treatment, and care services., J Acquir Immune Defic Syndr, 57, S96, 10.1097/QAI.0b013e31821db944

Meyer, 2014, Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate., JAMA Intern Med, 174, 721, 10.1001/jamainternmed.2014.601

Jordan, 2013, Correlates of nonadherence to antiretroviral therapy in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam., Int J STD AIDS, 25, 662, 10.1177/0956462413516301

Mann, 2012, Improved adherence to modern antiretroviral therapy among HIV-infected injecting drug users., HIV Med, 13, 596, 10.1111/j.1468-1293.2012.01021.x

Kerr, 2005, Determinants of HAART discontinuation among injection drug users., AIDS Care, 17, 539, 10.1080/09540120412331319778

Kim, 2007, Factors associated with discontinuation of antiretroviral therapy in HIV-infected patients with alcohol problems., AIDS Care, 19, 1039, 10.1080/09540120701294245

Maru, 2008, Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy., AIDS Behav, 12, 284, 10.1007/s10461-007-9336-2

Robison, 2008, Short-term discontinuation of HAART regimens more common in vulnerable patient populations., AIDS Res Hum Retroviruses, 24, 1347, 10.1089/aid.2008.0083

Werb, 2013, Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting., AIDS Behav, 17, 68, 10.1007/s10461-012-0136-y

Batista, 2014, Association between smoking, crack cocaine abuse and the discontinuation of combination antiretroviral therapy in Recife, Pernambuco, Brazil., Rev Inst Med Trop Sao Paulo, 56, 127, 10.1590/S0036-46652014000200007

Jiamsakul, 2014, Factors associated with suboptimal adherence to antiretroviral therapy in Asia., J Int AIDS Soc, 17, 18911, 10.7448/IAS.17.1.18911

Westergaard, 2013, Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users., AIDS, 27, 2559, 10.1097/QAD.0b013e328363bff2

Binford, 2012, A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs., Curr HIVAIDS Rep, 9, 287, 10.1007/s11904-012-0134-8

Thompson, 2012, Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel., Ann Intern Med, 156, 817, 10.7326/0003-4819-156-11-201206050-00419

Altice, 2007, Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial., Clin Infect Dis, 45, 770, 10.1086/521166

Hart, 2010, Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review., J Acquir Immune Defic Syndr, 54, 167, 10.1097/QAI.0b013e3181d9a330

Macalino, 2007, A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users., AIDS, 21, 1473, 10.1097/QAD.0b013e32811ebf68

Berg, 2011, Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial., Drug Alcohol Depend, 113, 192, 10.1016/j.drugalcdep.2010.07.025

Lucas, 2013, Directly administered antiretroviral therapy for HIV-infected individuals in opioid treatment programs: results from a randomized clinical trial., PLoS One, 8, e68286, 10.1371/journal.pone.0068286

Tran, 2012, Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnams injection-driven HIV epidemics., Drug Alcohol Depend, 125, 260, 10.1016/j.drugalcdep.2012.02.021

Altice, 2011, HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphinenaloxone treatment within HIV clinical care settings: results from a multisite study., J Acquir Immune Defic Syndr, 56, S22, 10.1097/QAI.0b013e318209751e

Springer, 2012, Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners., PLoS One, 7, e38335, 10.1371/journal.pone.0038335

Margolin, 2003, A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users., Health Psychol, 22, 223, 10.1037/0278-6133.22.2.223

Palepu, 2006, Antiretroviral adherence and HIV treatment outcomes among HIVHCV co-infected injection drug users: the role of methadone maintenance therapy., Drug Alcohol Depend, 84, 188, 10.1016/j.drugalcdep.2006.02.003

Uhlmann, 2010, Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users., Addiction, 105, 907, 10.1111/j.1360-0443.2010.02905.x

Hicks, 2007, The impact of illicit drug use and substance abuse treatment on adherence to HAART., AIDS Care, 19, 1134, 10.1080/09540120701351888

Kapadia, 2008, Impact of drug abuse treatment modalities on adherence to ARTHAART among a cohort of HIV seropositive women., Am J Drug Alcohol Abuse, 34, 161, 10.1080/00952990701877052

Feelemyer, 2014, Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an international systematic review., Drug Alcohol Depend, 134, 251, 10.1016/j.drugalcdep.2013.10.011

Bachireddy, 2014, Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine., Drug Alcohol Depend, 134, 106, 10.1016/j.drugalcdep.2013.09.020

Korthuis, 2011, Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics., J Acquir Immune Defic Syndr, 56, S39, 10.1097/QAI.0b013e318209754c

Lucas, 2010, Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: a randomized trial., Ann Intern Med, 152, 704, 10.7326/0003-4819-152-11-201006010-00003

Sulkowski, 2004, Hepatitis C virus infection in HIV-infected patients., Curr HIVAIDS Rep, 1, 128, 10.1007/s11904-004-0019-6

Friedland, 2010, Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis., J Acquir Immune Defic Syndr, 55, S37, 10.1097/QAI.0b013e3181f9c0b6

Anderson, 2014, 3rd, et al. Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans., Clin Infect Dis, 58, 719, 10.1093/cid/cit779

Erqou, 2014, Predictors of mortality among United States veterans with human immunodeficiency virus and hepatitis C virus coinfection., ISRN Gastroenterol, 2014, 764540, 10.1155/2014/764540

Hernando, 2012, All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection., J Hepatol, 57, 743, 10.1016/j.jhep.2012.06.010

Andreoni, 2012, HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications., Eur Rev Med Pharmacol Sci, 16, 1473

Aspinall, 2013, Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis., Clin Infect Dis, 57, S80, 10.1093/cid/cit306

Rotman, 2009, Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes., J Virol, 83, 7366, 10.1128/JVI.00191-09

Feeney, 2014, Antiviral treatment of hepatitis C., BMJ, 348, g3308, 10.1136/bmj.g3308

Zeremski, 2014, Editorial commentary: management of hepatitis C Virus in HIV-infected patients in the era of direct-acting antivirals., Clin Infect Dis, 58, 880, 10.1093/cid/cit804

Ford, 2012, Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis., Bull World Health Organ, 90, 540, 10.2471/BLT.11.097147

Hill, 2014, Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries., Clin Infect Dis, 58, 928, 10.1093/cid/ciu012

Getahun, 2012, Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services., Curr Opin HIV AIDS, 7, 345, 10.1097/COH.0b013e328354bd44

Getahun, 2013, Managing tuberculosis in people who use and inject illicit drugs., Bull World Health Organ, 91, 154, 10.2471/BLT.13.117267

Grenfell, 2013, Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature., Drug Alcohol Depend, 129, 180, 10.1016/j.drugalcdep.2012.11.013

Baussano, 2010, Tuberculosis incidence in prisons: a systematic review., PLoS Med, 7, e1000381, 10.1371/journal.pmed.1000381

Dara, 2013, Time to act to prevent and control tuberculosis among inmates., Int J Tuberc Lung Dis, 17, 4, 10.5588/ijtld.12.0909

Lawn, 2012, Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis., AIDS, 26, 1635, 10.1097/QAD.0b013e3283553685

Lawn, 2013, Advances in tuberculosis diagnostics: the Xpert MTBRIF assay and future prospects for a point-of-care test., Lancet Infect Dis, 13, 349, 10.1016/S1473-3099(13)70008-2

Steingart, 2014, Xpert(R) MTBRIF assay for pulmonary tuberculosis and rifampicin resistance in adults., Cochrane Database Syst Rev, 1, CD009593

Al-Darraji, 2013, The diagnostic performance of a single GeneXpert MTBRIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia., PLoS One, 9, e73717, 10.1371/journal.pone.0073717

Morozova, 2013, Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine., Int J Drug Policy, 24, e91, 10.1016/j.drugpo.2013.09.001

Selwyn, 1989, Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program., Ann Intern Med, 111, 761, 10.7326/0003-4819-111-9-761

OConnor, 1999, Tuberculosis chemoprophylaxis using a liquid isoniazid-methadone admixture for drug users in methadone maintenance., Addiction, 94, 1071, 10.1046/j.1360-0443.1999.947107112.x

Zahari, 2010, Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia., Am J Drug Alcohol Abuse, 36, 31, 10.3109/00952990903544828

Buckingham, 2013, Why the treatment of mental disorders is an important component of HIV prevention among people who inject drugs., Adv Prevent Med, 2013, 690386

Iskandar, 2012, Psychiatric comorbidity in injecting drug users in Asia and Africa., Curr Opin Psychiatry, 25, 213, 10.1097/YCO.0b013e3283523d66

Saber-Tehrani, 2011, Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence., Am J Drug Alcohol Abuse, 37, 1, 10.3109/00952990.2010.540279

Novick, 1997, Stigma and AIDS: three layers of damage., J Gay Lesbian Med Assoc, 1, 53, 10.1023/B:JOLA.0000007011.17392.fb

Earnshaw, 2014, Exploring intentions to discriminate against patients living with HIVAIDS among future healthcare providers in Malaysia., Trop Med Int Health, 19, 672, 10.1111/tmi.12306

Jin, 2014, An assessment of health-care students attitudes toward patients with or at high risk for HIV: implications for education and cultural competency., AIDS Care, 26, 1223, 10.1080/09540121.2014.894616

Lim, 2013, Individual-level socioeconomic status and community-level inequality as determinants of stigma towards persons living with HIV who inject drugs in Thai Nguyen, Vietnam., J Int AIDS Soc, 16, 18637, 10.7448/IAS.16.3.18637

Levi-Minzi, 2014, HIV stigma among substance abusing people living with HIVAIDS: implications for HIV treatment., AIDS Patient Care STDS, 28, 442, 10.1089/apc.2014.0076

Marsicano, 2014, Multiple discriminations experienced by people living with HIV in France: results from the ANRS-Vespa2 study., AIDS Care, 26, S97, 10.1080/09540121.2014.907385